Comparison of patients undergoing switching versus augmentation of antipsychotic medications during treatment for schizophrenia

Haya Ascher-SvanumLilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USACorrespondence[email protected]

Alan JM BrnabicLilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA

Anthony H LawsonLilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA

Bruce J KinonLilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA

Virginia L StaufferLilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA

Peter D FeldmanLilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA

Katarina KelinLilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA

show all

Pages 113-118 | Published online: 15 Mar 2012

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

CorrellCUAntipsychotic polypharmacy, part 1: Shotgun approach or targeted cotreatment?J Clin Psychiatry200869467467518507487
PubMed Web of Science ®Google Scholar
WeidenPJDiscontinuing and switching antipsychotic medications: understanding the CATIE schizophrenia trialJ Clin Psychiatry200768Suppl 1S1219
PubMed Web of Science ®Google Scholar
BuchananRWKreyenbuhlJKellyDLSchizophrenia Patient Outcomes Research Team (PORT)The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statementsSchizophr Bull2010361719319955390
PubMed Web of Science ®Google Scholar
LeuchtSHeresSKisslingWDavisJMEvidence-based pharmaco-therapy of schizophreniaInt J Neuropsychopharmacol201114226928421208500
PubMed Web of Science ®Google Scholar
MillerALHallCSBuchananRWThe Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 updateJ Clin Psychiatry200465450050815119912
PubMed Web of Science ®Google Scholar
BarnesTRPatonCAntipsychotic polypharmacy in schizophrenia: benefits and risksCNS Drugs201125538339921476610
PubMed Web of Science ®Google Scholar
PandurangiAKDalkilicAPolypharmacy with second-generation antipsychotics: a review of evidenceJ Psychiatr Pract200814634536719057237
PubMed Web of Science ®Google Scholar
TaylorDMirSMaceSCo-prescribing of atypical and typical antipsychotics – prescribing sequence and documented outcomePsychiatr Bull200226170172
Google Scholar
KelinKLambertTJBrnabicAJTreatment discontinuation and clinical outcomes in the 1-year naturalistic treatment of patients with schizophrenia at risk of treatment nonadherencePatient Prefer Adherence2011521322221660103
PubMed Web of Science ®Google Scholar
GuyWECDEU Assessment Manual for Psychopharmacology, Revised Publication ADM 76-338Bethesda, MDUnited States Department of Health, Education, and Welfare1976
Google Scholar
WareJJrKosinskiMKellerSDA 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validityMed Care19963432202338628042
PubMed Web of Science ®Google Scholar
EuroQol GroupEuroQol – a new facility for the measurement of health-related quality of lifeHealth Policy199016319920810109801
PubMed Web of Science ®Google Scholar
HoganTPAwadAGEastwoodRA self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validityPsychol Med19831311771836133297
PubMed Web of Science ®Google Scholar
AmadorXFStraussDHYaleSAFlaumMMEndicottJGormanJMAssessment of insight in psychosisAm J Psychiatry199315068738798494061
PubMed Web of Science ®Google Scholar
KaplanELMeierPNonparametric estimation from incomplete observationsJ Am Stat Assoc195853282457481
Web of Science ®Google Scholar
CohenJStatistical Power Analysis for the Behavioral SciencesNew York, NYAcademic Press1969
Google Scholar
GanguliRRationale and strategies for switching antipsychoticsAm J Health Syst Pharm20025922 Suppl 8S222612455296
PubMed Web of Science ®Google Scholar
HugenholtzGWHeerdinkERMeijerWEStolkerJJEgbertsACNolenWAReasons for switching between antipsychotics in daily clinical practicePharmacopsychiatry200538312212415902582
PubMed Web of Science ®Google Scholar
TsutsumiCUchidaHSuzukiTThe evolution of antipsychotic switch and polypharmacy in natural practice – a longitudinal perspectiveSchizophr Res20111301–3404621624824
PubMed Web of Science ®Google Scholar
Ayuso-GutiérrezJLdel Río VegaJMFactors influencing relapse in the long-term course of schizophreniaSchizophr Res1997282–31992069468354
PubMed Web of Science ®Google Scholar
LindströmEBingeforsKPatient compliance with drug therapy in schizophrenia. Economic and clinical issuesPharmacoeconomics200018210612411067646
PubMed Web of Science ®Google Scholar
Ascher-SvanumHFariesDEZhuBErnstFRSwartzMSSwansonJWMedication adherence and long-term functional outcomes in the treatment of schizophrenia in usual careJ Clin Psychiatry200667345346016649833
PubMed Web of Science ®Google Scholar
LindenmayerJPLiu-SeifertHKulkarniPMMedication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior responseJ Clin Psychiatry200970799099619497244
PubMed Web of Science ®Google Scholar
LiebermanJAStroupTSMcEvoyJPClinical Antipsychotic Trials of Intervention Effectiveness (CATIE) InvestigatorsEffectiveness of antipsychotic drugs in patients with chronic schizophreniaN Engl J Med2005353121209122316172203
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Comparison of patients undergoing switching versus augmentation of antipsychotic medications during treatment for schizophrenia

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Comparison of patients undergoing switching versus augmentation of antipsychotic medications during treatment for schizophrenia

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date